Zentalis Pharmaceuticals Inc (ZNTL)
11.71
+0.60
(+5.40%)
USD |
NASDAQ |
May 03, 16:00
11.71
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Cash from Investing (Quarterly): -42.06M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -42.06M |
| September 30, 2023 | -117.45M |
| June 30, 2023 | 72.93M |
| March 31, 2023 | 42.12M |
| December 31, 2022 | -11.89M |
| September 30, 2022 | 20.02M |
| June 30, 2022 | -142.10M |
| March 31, 2022 | 19.80M |
| December 31, 2021 | 43.27M |
| September 30, 2021 | -141.44M |
| Date | Value |
|---|---|
| June 30, 2021 | 66.60M |
| March 31, 2021 | 13.46M |
| December 31, 2020 | -9.65M |
| September 30, 2020 | -137.89M |
| June 30, 2020 | -137.26M |
| March 31, 2020 | -0.031M |
| December 31, 2019 | -0.036M |
| September 30, 2019 | -0.107M |
| June 30, 2019 | -0.168M |
| March 31, 2019 | -0.041M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-142.10M
Minimum
Jun 2022
72.93M
Maximum
Jun 2023
-24.31M
Average
-0.107M
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Revolution Medicines Inc | -380.40M |
| Day One Biopharmaceuticals Inc | 30.38M |
| Perspective Therapeutics Inc | -0.089M |
| Electromed Inc | -0.087M |
| Xtant Medical Holdings Inc | -2.313M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.60M |
| Free Cash Flow | -208.40M |
| Free Cash Flow Per Share (Quarterly) | -0.5756 |
| Free Cash Flow Yield | -27.22% |